Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Salesforce
CRM
|
$956M |
| 2 |
Analog Devices
ADI
|
$736M |
| 3 |
Cisco
CSCO
|
$427M |
| 4 |
Merck
MRK
|
$427M |
| 5 |
NetEase
NTES
|
$421M |
Top Sells
| 1 |
Alibaba
BABA
|
$1.2B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
$898M |
| 3 |
Procter & Gamble
PG
|
$559M |
| 4 |
Oracle
ORCL
|
$471M |
| 5 |
Capital One
COF
|
$456M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Financials | 13.4% |
| 3 | Healthcare | 12.62% |
| 4 | Consumer Discretionary | 12.45% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3726
PureCycle Technologies
PCT
$2.41B
| $155K | ﹤0.01% |
11,699
+2,877
| +33% | +$38.1K |
|
3727
CytomX Therapeutics
CTMX
$376M
| $154K | ﹤0.01% |
30,175
+4,850
| +19% | +$24.8K |
|
3728
Esperion Therapeutics
ESPR
$540M
| $153K | ﹤0.01% |
12,667
+2,037
| +19% | +$24.6K |
|
|
KDNY
3729
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $153K | ﹤0.01% |
11,992
+1,512
| +14% | +$19.3K |
|
3730
First Bank
FRBA
$421M
| $152K | ﹤0.01% |
+10,773
| New | +$152K |
|
|
CRON
3731
Cronos Group
CRON
$957M
| $149K | ﹤0.01% |
26,286
+392
| +2% | +$2.22K |
|
3732
Altimmune
ALT
$334M
| $147K | ﹤0.01% |
12,940
+2,502
| +24% | +$28.4K |
|
3733
NeueHealth
NEUE
$60.3M
| $147K | ﹤0.01% |
+226
| New | +$147K |
|
3734
Limbach Holdings
LMB
$1.25B
| $146K | ﹤0.01% |
22,064
+773
| +4% | +$5.12K |
|
3735
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $145K | ﹤0.01% |
12,736
+1,751
| +16% | +$19.9K |
|
3736
Aterian
ATER
$9.76M
| $144K | ﹤0.01% |
+1,104
| New | +$144K |
|
3737
CBAK Energy Technology
CBAT
$81.8M
| $144K | ﹤0.01% |
61,939
+11,020
| +22% | +$25.6K |
|
3738
Culp
CULP
$53.6M
| $144K | ﹤0.01% |
11,204
+390
| +4% | +$5.01K |
|
|
STKL
3739
SunOpta
STKL
$779M
| $143K | ﹤0.01% |
16,063
+247
| +2% | +$2.2K |
|
3740
Nuvve Holding Corp
NVVE
$4.21M
| $141K | ﹤0.01% |
33
+6
| +22% | +$25.6K |
|
3741
Lineage Cell Therapeutics
LCTX
$279M
| $140K | ﹤0.01% |
55,643
+11,196
| +25% | +$28.2K |
|
|
CEN
3742
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
| $140K | ﹤0.01% |
+10,029
| New | +$140K |
|
3743
Cartesian Therapeutics
RNAC
$277M
| $139K | ﹤0.01% |
1,112
+141
| +15% | +$17.6K |
|
|
SFT
3744
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $139K | ﹤0.01% |
2,002
+374
| +23% | +$26K |
|
3745
DNP Select Income Fund
DNP
$3.67B
| $138K | ﹤0.01% |
12,942
-19,602
| -60% | -$209K |
|
|
LUNA
3746
DELISTED
Luna Innovations Incorporated
LUNA
| $138K | ﹤0.01% |
14,526
+3,661
| +34% | +$34.8K |
|
3747
Flotek Industries
FTK
$336M
| $136K | ﹤0.01% |
17,930
+627
| +4% | +$4.76K |
|
3748
TherapeuticsMD
TXMD
$12.5M
| $136K | ﹤0.01% |
3,688
+638
| +21% | +$23.5K |
|
3749
Zevra Therapeutics
ZVRA
$502M
| $136K | ﹤0.01% |
14,644
+3,314
| +29% | +$30.8K |
|
|
GER
3750
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
| $136K | ﹤0.01% |
12,635
-6,476
| -34% | -$69.7K |
|